Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (301-310 of 364) with videos related to

Pageof 37
Sort By:
Acta Neuropathologica|April 2, 2020
Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizooticO Noel Gill, Yvonne Spencer, Angela Richard-Loendt, et al.
Bulletin of the World Health Organization|March 28, 2008
Towards elimination: measles susceptibility in Australia and 17 European countriesNick Andrews, Annedore Tischer, Annette Siedler, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The New England Journal of Medicine|January 12, 2022
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesNick Andrews, Elise Tessier, Julia Stowe, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 5, 2015
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season resultsRichard Pebody, Fiona Warburton, Nick Andrews, et al.
BMC Public Health|March 12, 2021
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health recordsJemma L Walker, Daniel J Grint, Helen Strongman, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
BMJ Open|June 29, 2022
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocolSarah Wallace, Victoria Hall, Andre Charlett, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2026
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Heloise Lucaccioni, Diogo Fp Marques, Freja Kirsebom, et al.
Pageof 37

Showing results (301-310 of 364) with videos related to

Sort By:
Pageof 37
Acta Neuropathologica|April 2, 2020
Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizooticO Noel Gill, Yvonne Spencer, Angela Richard-Loendt, et al.
Bulletin of the World Health Organization|March 28, 2008
Towards elimination: measles susceptibility in Australia and 17 European countriesNick Andrews, Annedore Tischer, Annette Siedler, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The New England Journal of Medicine|January 12, 2022
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesNick Andrews, Elise Tessier, Julia Stowe, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 5, 2015
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season resultsRichard Pebody, Fiona Warburton, Nick Andrews, et al.
BMC Public Health|March 12, 2021
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health recordsJemma L Walker, Daniel J Grint, Helen Strongman, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.
BMJ Open|June 29, 2022
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocolSarah Wallace, Victoria Hall, Andre Charlett, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2026
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Heloise Lucaccioni, Diogo Fp Marques, Freja Kirsebom, et al.
Pageof 37